Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind,…

By J. Fitzgerald, E. Bleecker, Parameswaran Nair, Stephanie Korn, Ken Ohta, M. Lommatzsch, G. Ferguson, W. Busse, P. Barker, Stephanie Sproule and 4 more. The Lancet, 2016

1,156 citations recorded by the source corpus.

Subfields: Emergency Medical Services, Physiology, Sociology and Political Science

View Paper: https://www.semanticscholar.org/paper/4b055c4a2196cdcb55c7b94095906005358a233b